Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum Malaria

Stopped Company decision to modify the ferroquine development strategy; discontinuation not due to safety or activity unexpected findings

Conditions

• Plasmodium Falciparum Infection

Interventions

• DRUG: Ferroquine (SSR97193)
• DRUG: Placebo
• DRUG: artesunate

Sponsor

Sanofi